{
    "Trade/Device Name(s)": [
        "AllTest Multi-Drug Urine Test Cup",
        "AllTest Multi-Drug Rapid Urine Test Cup"
    ],
    "Submitter Information": "Hangzhou AllTest Biotech Co., Ltd.",
    "510(k) Number": "K241428",
    "Predicate Device Reference 510(k) Number(s)": [
        "K233019"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "PTH",
        "NGL",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "NGM",
        "QAW",
        "NFW"
    ],
    "Summary Letter Date": "May 16, 2024",
    "Summary Letter Received Date": "May 20, 2024",
    "Submission Date": "June 15, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Barbiturate test system",
        "Opiate test system",
        "Benzodiazepine test system",
        "Cocaine and cocainemetabolite test system",
        "Methadone test system",
        "Methamphetamine test system",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoids test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine (AMP)",
        "Buprenorphine (BUP)",
        "Secobarbital (BAR)",
        "Oxazepam (BZO)",
        "Cocaine (COC)",
        "Methamphetamine (MET)",
        "Methylenedioxymethamphetamine (MDMA)",
        "Morphine (MOP/OPI)",
        "Methadone (MTD)",
        "Oxycodone (OXY)",
        "Phencyclidine (PCP)",
        "Nortriptyline (TCA)",
        "Marijuana (THC)",
        "Fentanyl (FYL)"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        "Cup format"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Immunochromatographic",
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cup",
        "Rapid Test",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for AllTest Multi-Drug Urine Test Cup and AllTest Multi-Drug Rapid Urine Test Cup for qualitative and simultaneous detection of multiple drugs of abuse in human urine using competitive lateral flow immunochromatographic assay.",
    "Indications for Use Summary": "Qualitative, simultaneous detection of amphetamine, buprenorphine, secobarbital, oxazepam, cocaine, methamphetamine, MDMA, morphine, methadone, oxycodone, phencyclidine, nortriptyline, marijuana, and fentanyl in human urine for in vitro and OTC use; provides preliminary results for prescription drug detection, requiring confirmatory testing by GC/MS or LC/MS.",
    "fda_folder": "Toxicology"
}